Intended Use

This device is intended for use in surgical procedures to assist in locating and mapping motor nerves through the use of mechanomyographic (MMG) signals and electrical stimulus of nerves. The device provides information directly to the surgeon to help assess a patient's neurophysiologic status by measuring and comparing MMG signals throughout a surgical procedure. The device identifies relative changes in the conduction and neural transmission ability of the nerve by measuring minimum electrical stimulation current (mA) needed to induce a measurable MMG response.

Technology

The Neuralytix iD3 System is a multichannel device that uses electrical stimulation and mechanomyographic sensors (accelerometers) to detect muscle activity in response to nerve stimulation. It provides real-time visual and auditory alerts to the surgeon through a touchscreen graphical user interface, measuring nerve response thresholds with digitally controlled stimulation currents. The device includes disposable sensor patches and stimulation probes made of biocompatible materials, functioning through constant current monophasic rectangular pulses.

Performance

Non-clinical testing was conducted including design controls, risk management, electrical safety, software validations, biocompatibility, and comparative performance against predicate device Sentio MMG Gen 2. The device demonstrated >99% agreement in MMG signal detection with the predicate, passed sterility and packaging integrity tests, and met all acceptance criteria for electrical, environmental, and user interface performance, confirming substantial equivalence and safe function.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    11/25/2024

    7 months
  • 2

    FDA Approval

    6/26/2025

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.